Prospective Open Label Randomized Controlled Clinical Study Evaluating the Efficacy of Perceptual Learning in Improving Vision among Patients with Congenital Nystagmus

Idan Hecht MD1,2, Sigal Zmujack-Yehiam MD1,2, Ora Abaev1, Adi Einan-Lifshitz MD1,2, Eran Pras MD1,2

  1. Department of Ophthalmology, Shamir Medical Center, Zerifin, Israel.
  2. Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

 

Idan Hecht MD1,2, Sigal Zmujack-Yehiam MD1,2, Ora Abaev1, Adi Einan-Lifshitz MD1,2, Eran Pras MD1,2

  1. Department of Ophthalmology, Shamir Medical Center, Zerifin, Israel.
  2. Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

 

Background: There are limited treatment options to improve vision in patients with congenital nystagmus. We examined the use of repeated visual stimulation with Gabor Patches to achieve that goal.

 

Methods: In a prospective randomized (3:1) controlled open label study, patients aged 9-55 years with congenital nystagmus and best corrected visual acuity (BCVA) between 20/40–20/200 were included. The treatment group underwent visual stimulation for four months, controls were treated with sham stimuli. BCVA, contrast sensitivity, and stereoacuity were assessed.

 

Results: 26 patients were treated and 10 served as control. Mean age was 22.47±12 years. 6/26 (23%) of treatment subjects achieved driving license BCVA (20/40) vs 1/10 (10%) of controls. Distance treated BCVA improved by 0.10±0.07 logMAR (one ETDRS line) compared with 0.015±0.09 logMAR in controls (p=0.006). Near BCVA improved by 0.16±0.14 logMAR (1.6 ETDRS lines) compared with 0.05±0.13 logMAR in controls (p=0.040). 88% (8/9) of study patients who had no binocularity prior to treatment achieved binocularity (mean 630’) as opposed to 25% (1/4) of controls (p=0.10). Mean stereoacuity and contrast sensitivity improved by 801±730’ and 292±391% in the study group as opposed to 246±376’ and 152±67% in controls respectively (p=0.031; p=0.157).

 

Conclusions: Visual perceptual learning using Gabor Patches resulted in a significant improvement in near and distance visual acuity, which allowed 23% of patients to achieve a driving license BCVA. A corresponding improvement in stereopsis was noted, and 88% of patients with no binocularity gained it. Further studies will identify which patients will benefit most from this treatment.

 

Background: There are limited treatment options to improve vision in patients with congenital nystagmus. We examined the use of repeated visual stimulation with Gabor Patches to achieve that goal.

 

Methods: In a prospective randomized (3:1) controlled open label study, patients aged 9-55 years with congenital nystagmus and best corrected visual acuity (BCVA) between 20/40–20/200 were included. The treatment group underwent visual stimulation for four months, controls were treated with sham stimuli. BCVA, contrast sensitivity, and stereoacuity were assessed.

 

Results: 26 patients were treated and 10 served as control. Mean age was 22.47±12 years. 6/26 (23%) of treatment subjects achieved driving license BCVA (20/40) vs 1/10 (10%) of controls. Distance treated BCVA improved by 0.10±0.07 logMAR (one ETDRS line) compared with 0.015±0.09 logMAR in controls (p=0.006). Near BCVA improved by 0.16±0.14 logMAR (1.6 ETDRS lines) compared with 0.05±0.13 logMAR in controls (p=0.040). 88% (8/9) of study patients who had no binocularity prior to treatment achieved binocularity (mean 630’) as opposed to 25% (1/4) of controls (p=0.10). Mean stereoacuity and contrast sensitivity improved by 801±730’ and 292±391% in the study group as opposed to 246±376’ and 152±67% in controls respectively (p=0.031; p=0.157).

 

Conclusions: Visual perceptual learning using Gabor Patches resulted in a significant improvement in near and distance visual acuity, which allowed 23% of patients to achieve a driving license BCVA. A corresponding improvement in stereopsis was noted, and 88% of patients with no binocularity gained it. Further studies will identify which patients will benefit most from this treatment.

 


Back to Blog

CONTACT US

    Talshir Medical Technologies LTD
    Hama’ayan Street 2, Modi’in 7177871, Israel
    USA Phone: 1.800.361.8218 | Main Office: +972.77.212.3272

    info@revitalvision.com
    Contact background